Cancerous Patient, COVID‑19 Vaccination, Blood Viscosity and Stroke‑Like Complication

Beuy Joob Joob, Viroj Wiwanitkti

Abstract


Dear Editor, The coronavirus disease 2019 (COVID‑19) vaccine is the hope for the management of the COVID‑19 outbreak. At present, the COVID‑19 vaccine is already in use in several countries. An important concern is the adverse effect of vaccination. There are many possible adverse effects of the COVID‑19 vaccine including vascular complication. The possible neurological complication due to the COVID‑19 vaccine is an important present consideration.[1] There are many recent reports on neurological incidences including stroke‑like complication after vaccination.

Keywords


Blood Viscosity; COVID‑19; Stroke‑Like Complication; Vaccination

References


Lu L, Xiong W, Mu J, Zhang Q, Zhang H, Zou L, et al. The

potential neurological effect of the COVID‑19 vaccines:

A review. Acta Neurol Scand 2021. doi: 10.1111/ane. 13417.

Online ahead of print.

Saadat S, Tehrani ZR, Logue J, Newman M, Frieman MB,

Harris AD, et al. Binding and neutralization antibody titers after

a single vaccine dose in health care workers previously infected

with SARS‑CoV‑2. JAMA 2021;325:1467‑9.

Dalakas MC. High‑dose intravenous immunoglobulin and

serum viscosity: Risk of precipitating thromboembolic events.

Neurology 1994;44:223‑6.

von Tempelhoff G‑F, Schönmann N, Heilmann L, Pollow K,

Hommel G. Prognostic role of plasmaviscosity in breast cancer.

Clin Hemorheol Microcirc 2002;26:55‑61.